Inhibitors of serine proteases
US7985762B2 · kind B2 · utility
4Cited by
107References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2006 |
| Grant date | Jul 26, 2011 |
| Priority date | — |
| Expiry date | Mar 22, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I:or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3—NS4A protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.